Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Vaxil Bio Ltd V.VXL

Alternate Symbol(s):  VXLLF

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.


TSXV:VXL - Post by User

Comment by bligickaon Nov 23, 2020 11:00am
51 Views
Post# 31952155

RE:RE:RE:RE:PRIVATE PLACEMENT EXTENSION

RE:RE:RE:RE:PRIVATE PLACEMENT EXTENSIONSo why does he claim to be such a great strategist !!!  

As CEO he is completely in control and also responsible for the situation Vaxil is in presently !!!

I think he is incapable of making strategic decisions for thisa company and needs to be replaced with someone who can move quicker, is more investor friendly and willing to get off his asss and capitalize on nondilutive funds available from goverment or licensing deals !!!


Charleyfarley wrote:
Mr Goren is not the one running this latest Private Placement . The Board members who actually have Contributed Funds to this Companies Advancement in the Scientific Community are the Disappointed . Mr Goren , as we will find out is not the one who makes the Corporate decisions when it comes to Funding. Mr Goren was Hired initially due to his past Scientific Involvement in the BIO Industry with the top Companies. That as far as I am Aware is where his Involvement ends.


<< Previous
Bullboard Posts
Next >>